Pronađeno: 1-2 / 2 radova

Autori: Sierzega M

>> Filter: Samo Article i Review

Naslov Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension (Meeting Abstract)
Autori Bar-Or Amit  Oh J  Dufek Michal  Budincevic Hrvoje  Habek Mario  Caunt Maresa  Harp C  Sierzega M  Clayton David  Chen Y  Ratchford JN  Goodyear Alexandra  Drulovic Jelena S 
Info MULTIPLE SCLEROSIS JOURNAL, (2025), vol. 31 br. 2_SUPPL, Suppl. 2_SUPPL, str. 244-244
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 Trial (Meeting Abstract)
Autori Hua Le  Bar-Or Amit  Weber Martin  Habek Mario  Budincevic Hrvoje  Thomas Piia  Napieralski Julie  Ratchford John  Qi Qi  Sierzega M  Drulovic Jelena S 
Info EUROPEAN JOURNAL OF NEUROLOGY, (2023), vol. 30 br. , Suppl. 1, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Ispis zapisa u formatu:TXT | BibTeX